Streetbeat News

Stock Prices

OCFS

PSN

SHLD

Parsons Corporation (NYSE:PSN) shares rose after securing a $68.5M contract from the U.S. Army Corps of Engineers for building army housing in the Kwajalein Atoll. This is Parsons' second such contract in a year, and they are also on the Pre-Qualified Source Listing for future large orders. The stock is up 5.54% following the news.

Portfolio Pulse from Lekha Gupta

September 09, 2024 | 4:11 pm

SINT

SINTX Technologies Inc (NASDAQ:SINT) shares surged 91.5% after receiving a Notice of Allowance for a patent on zirconia-toughened alumina surface functionalization methods. This patent enhances their intellectual property portfolio and supports the development of new biomaterials for medical applications.

Portfolio Pulse from Henry Khederian

September 09, 2024 | 4:10 pm

AVBP

ArriVent BioPharma announced positive interim data from its Phase 1b trial of firmonertinib for EGFR PACC mutant NSCLC, showing high response rates. The company will host a webinar to discuss these findings.

Portfolio Pulse from Benzinga Newsdesk

September 09, 2024 | 4:07 pm

AMCX

EGIO

INBS

PEGY

RLAY

SINT

U.S. stocks rose with the Nasdaq surging over 1% as wholesale inventories increased by 0.2% in July. Notable stock movements included Sintx Technologies, Intelligent Bio Solutions, and Relay Therapeutics, which saw significant gains, while Edgio, Pineapple Energy, and AMC Networks experienced declines.

Portfolio Pulse from Avi Kapoor

September 09, 2024 | 4:04 pm

GME

GameStop Corp (NYSE:GME) is set to report its Q2 earnings, with analysts expecting a revenue decline and a loss per share. The company has missed revenue and earnings estimates in recent quarters. Investors are keen on updates regarding cash usage and potential M&A activities. GameStop shares have risen 43% YTD but have recently pulled back.

Portfolio Pulse from Chris Katje

September 09, 2024 | 4:02 pm

XLE

XLU

Bank of America has adjusted its sector outlooks, upgrading Utilities to 'overweight' and downgrading Energy to 'market-weight'. Utilities, represented by XLU, are seen as a defensive hedge with growth potential due to stable fundamentals and AI integration. Energy, represented by XLE, faces political risks and negative earnings revisions, making it a less attractive investment.

Portfolio Pulse from Piero Cingari

September 09, 2024 | 4:02 pm

AXSM

Axsome Therapeutics (NASDAQ:AXSM) has been analyzed by 17 analysts, showing a range of opinions from bullish to bearish. The average 12-month price target is $129.06, with a high of $180.00 and a low of $95.00. Recent ratings show a mix of 'Maintain', 'Raise', and 'Lower' actions, reflecting dynamic market conditions. Axsome's revenue growth is strong, but profitability metrics like net margin and ROE are below industry averages.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 4:01 pm

EPR

EPR Properties (NYSE:EPR) has been evaluated by six analysts over the past three months, with ratings ranging from bullish to bearish. The average 12-month price target has increased by 5.39% to $48.92. Analysts have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Despite a recent revenue decline, EPR Properties maintains strong profitability and effective cost management.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 4:01 pm

NIO

NIO has seen significant bullish options activity, with 54% of traders showing positive sentiment. The stock price has risen by 5.58% to $5.3, and analysts have set price targets between $5 and $8. The options market shows a focus on a price range of $3.0 to $7.5.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 4:00 pm

GS

Investors with significant capital have shown a bearish sentiment towards Goldman Sachs Gr (NYSE:GS) through options trading. Benzinga's options scanner identified 28 unusual trades, with 53% being bearish. The trading activity suggests a focus on a price range between $165.0 and $520.0. Despite this, GS's stock price is up 2.26% at $490.46, with a neutral RSI. An analyst from JP Morgan maintains an Overweight rating with a target price of $472.

Portfolio Pulse from Benzinga Insights

September 09, 2024 | 4:00 pm